INOCA and MINOCA are conditions with high risk of cardiac events and frequent persistent ischemic symptoms, and aggressive intervention is needed to reduce risk and symptom burden. This episode will review the data on contemporary treatment of INOCA and MINOCA and discuss additional strategies beyond the data and future directions.

In this interview, Jamieson Bourque, MD., MHS., FACCE and Magnus Ohman MD, FACC, with Michelle D. Kelsey MD, ask if there is evidence for treatment, and discuss data-driven management of in-patients with INOCA and MINOCA.

We have never had a symptoms-based guideline before. Why was it time for these new Chest Pain Guidelines? How does shared decision-making come into the assessment of chest pain? Is anatomic or functional testing preferred in the evaluation or acute chest pain or stable chest pain?

In this interview, Martha Gulati MD MS FACC FAHA FASPC FESC and Christopher M. Kramer MD, FACC, with Nosheen Reza MD, discuss the top controversies behind the Chest Pain Guideines.

In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.

The highly anticipated newest iteration of the Chronic Heart Failure Guidelines are finally here. What updates are most important to clinicians, and how can they be most effectively implemented in clinical practice?

In this interview, Michelle Kittleson MD, PhD and Clyde W. Yancy MD, FACC, with Hilary Shapiro, MD MSc, discuss how to implement the new HF Guidelines into your practice.

Any of us could suffer a nonfatal cardiac arrest. Sudden cardiac arrest is not limited to patients with heart disease. Even athletes could have a sudden and unexpected cardiac arrest. We must be prepared as society (external defibrillators and CRP) but also as cardiologists (to perform the correct studies).

In this interview, Manlio Marquez, MD, FACC and Jeroen J. Bax PhD, MD, FACC, with Zain Ul Abideen Asad MD, discuss how one should perform an investigation of a survivor of sudden cardiac arrest.

What do the new Chest Pain Guidelines say about additional noninvasive testing for low risk and intermediate risk patients? Is relief of chest pain with nitroglycerin diagnostic of myocardial ischemia?

In this interview, Debabrata Mukherjee, MD, MS and Jeroen J. Bax PhD, MD, FACC, with Jonathan R. Salik, MD, discuss these questions and other top takeaways for the practicing clinician: from the Chest Pain Guidelines.

Death due to pulmonary embolism remains high, despite increased attention and advances in various medications and treatment techniques. Surgical treatment of acute PE is safe and highly effective at saving lives.

In this interview, Joshua B. Goldberg, MD and C. Noel Bairey Merz MD, FACC, with Michelle D. Kelsey MD, discuss Modern Managment of High-Risk PE.

Peri-partum cardiomyopathy is a form of heart failure affecting young mothers during later stages of pregnancy or early post-partum. Medical management should be tailored to improving the mother's health while ensuring safety of the baby.

Which of the currently available heart failure drugs are safe in pregnancy and during breast feeding? What are the outcomes of women with peripartum cardiomyopathy, who undergo LVAD implantation or heart transplantation?

In this interview, Dharini Ramu, MD, FACC and Spencer B. King III, MD, MACC, with Yuvraj Chowdhury MD, discuss Medical and Advanced Heart Failure Therapies in Peri-partum cardiomyopathy: A Cardiologist’s Perspective.

Women with preeclampsia and related hypertensive disorders of pregnancy have increased risk of heart disease compared with women who experienced uncomplicated pregnancy. Women should ensure treating clinicians know their reproductive history, and clinicians should work to aggressively prevent and treat development of cardiovascular risk factors in women with a history of preeclampsia.

In this interview, Michael Honigberg, MD, MPP, FACC and Glenn A. Hirsch MD, MHS, FACC, with Yuvraj Chowdhury MD, discuss Pre-Eclampsia: Maternal Red Flag of Risk.

The United States is the only developed country with rising rates of death during pregnancy and up to one year postpartum. The maternal mortality crisis is disproportionately impacting women of color, specifically Black women who are 3 times as likely to die. This is regardless of education, income or profession and most notably is as a result of psychosocial stressors, including racism.

In this interview, Rachel M Bond, MD, FACC and Alison L. Bailey, MD FACC, with Michelle D. Kelsey MD, discuss Black Maternal Health: A Call to Action and Implications for Prevention.